umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
ELUCIDATING THE MECHANISM OF RECEPTOR TYROSINE KINASE INHIBITION BY SOLUBLE LRIG1 IN GLIOBLASTOMA
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
2013 (English)In: Neuro-Oncology, ISSN 1522-8517, E-ISSN 1523-5866, Vol. 15, no Supplement: 3, 28-29 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Oxford University Press, 2013. Vol. 15, no Supplement: 3, 28-29 p.
National Category
Cancer and Oncology Neurology
Identifiers
URN: urn:nbn:se:umu:diva-85806ISI: 000327456200118OAI: oai:DiVA.org:umu-85806DiVA: diva2:695887
Conference
4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO) held in conjunction with the 18th Annual Meeting of the Society-for-Neuro-Oncology (SNO), NOV 21-24, 2013, San Francisco, CA
Available from: 2014-02-12 Created: 2014-02-10 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Hedman, Håkan
By organisation
Oncology
In the same journal
Neuro-Oncology
Cancer and OncologyNeurology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 86 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf